These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 19354063)

  • 1. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
    Lee C; Gianos M; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization.
    Pagani M
    Med Clin North Am; 2010 Jul; 94(4):835-52, xiii. PubMed ID: 20609866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and preparedness for infusion and hypersensitivity reactions.
    Lenz HJ
    Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of hypersensitivity reactions to antineoplastic agents.
    Cortijo-Cascajares S; Jiménez-Cerezo MJ; Herreros de Tejada A
    Farm Hosp; 2012; 36(3):148-58. PubMed ID: 22484106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.
    Leguy-Seguin V; Jolimoy G; Coudert B; Pernot C; Dalac S; Vabres P; Collet E
    J Allergy Clin Immunol; 2007 Mar; 119(3):726-30. PubMed ID: 17258305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events to nontargeted and targeted chemotherapeutic agents: emphasis on hypersensitivity responses.
    Baldo BA; Pagani M
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):565-96, viii. PubMed ID: 25017678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity reactions to antineoplastic agents: an overview.
    Syrigou E; Makrilia N; Koti I; Saif MW; Syrigos KN
    Anticancer Drugs; 2009 Jan; 20(1):1-6. PubMed ID: 19342995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
    Pagani M; Bonadonna P; Senna GE; Antico A
    Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and management of hypersensitivity reactions to chemotherapy agents.
    Tham EH; Cheng YK; Tay MH; Alcasabas AP; Shek LP
    Postgrad Med J; 2015 Mar; 91(1073):145-50. PubMed ID: 25659930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.
    Kuo JC; Hawkins C; Yip D
    Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
    Hewitt MR; Sun W
    Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin.
    Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML
    J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy.
    Caiado J; Venemalm L; Pereira-Santos MC; Costa L; Barbosa MP; Castells M
    J Allergy Clin Immunol Pract; 2013; 1(5):494-500. PubMed ID: 24565621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy and biotherapy-induced hypersensitivity reactions.
    Van Gerpen R
    J Infus Nurs; 2009; 32(3):157-65. PubMed ID: 19444023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol.
    Syrigou E; Dannos I; Kotteas E; Makrilia N; Tourkantonis I; Dilana K; Gkiozos I; Saif MW; Syrigos KN
    Int Arch Allergy Immunol; 2011; 156(3):320-4. PubMed ID: 21720178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and handling of acute allergic and infusion reactions in oncology.
    Joerger M
    Ann Oncol; 2012 Sep; 23 Suppl 10():x313-9. PubMed ID: 22987983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.